Tag: NASDAQ:FGEN

In a filing, FibroGen Inc revealed its Chief Medical Officer Adib Deyaa acquired Company’s shares for reported $25884.0 on Jun

FibroGen Inc’s recent filing unveils that its Chief Medical Officer Adib Deyaa acquired Company’s shares for reported $25884.0 on Jun

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. FibroGen Inc

FibroGen Inc’s recent filing unveils that its Chief Medical Officer Adib Deyaa acquired Company’s shares for reported $25884.0 on Jun

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

FibroGen Inc’s recent filing unveils that its Chief Medical Officer Adib Deyaa acquired Company’s shares for reported $25884.0 on Jun